One problem with drug discovery and development is that answers about the way substances act in the human body are often not apparent early in the process. Though human cell assays have been used, they have their limitations. BioSeek’s BioMap technology seeks to improve the success rate of research and development by bringing the complexity of human biology to cell assays and incorporating that into the earliest stages of drug discovery process. We spoke to Ellen Berg, director and general manager at BioSeek, about the company’s technology, how it seeks to improve discovery and development, and other ways the technology is being used by the industry.